Schonfeld Strategic Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 3,892 shares of REGN stock, worth $2.78 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,892

Previous 1,400 178.0%

Holding current value

$2.78 Million

Previous $1.47 Million 178.11%

% of portfolio

0.03%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $2.55 Million - $2.99 Million	2,492 Added 178.0%	3,892 $4.09 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $1.24 Million - $1.5 Million	1,400 New	1,400 $1.47 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $1.97 Million - $2.24 Million	-2,535 Reduced 62.83%	1,500 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $2.17 Million - $2.64 Million	3,127 Added 344.38%	4,035 $3.32 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $1.9 Million - $2.26 Million	-2,720 Reduced 74.97%	908 $652,000
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $2.47 Million - $3 Million	3,628 New	3,628 $2.98 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $4.82 Million - $6.08 Million	-8,400 Reduced 60.96%	5,380 $3.71 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $6.86 Million - $9.25 Million	12,519 Added 992.78%	13,780 $8.15 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $750,446 - $880,720	1,261 New	1,261 $881,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $946,198 - $1.17 Million	-1,741 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$574.03 - $680.96 $10 Million - $11.9 Million	-17,432 Reduced 90.92%	1,741 $1.05 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $4.56 Million - $5.38 Million	9,638 Added 101.08%	19,173 $10.7 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $3.54 Million - $4.35 Million	7,935 Added 495.94%	9,535 $4.51 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $765,280 - $972,768	1,600 New	1,600 $773,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $1.21 Million - $1.58 Million	-2,454 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $824,985 - $1.21 Million	2,454 New	2,454 $1.2 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $1.72 Million - $2.01 Million	-6,300 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $1.86 Million - $2.57 Million	-6,200 Reduced 49.6%	6,300 $1.97 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $3.4 Million - $4.02 Million	-9,144 Reduced 42.25%	12,500 $5.13 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $6.43 Million - $7.72 Million	19,144 Added 765.76%	21,644 $8.08 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $842,736 - $980,424	-2,400 Reduced 48.98%	2,500 $1.01 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.39 Million - $1.69 Million	4,900 New	4,900 $1.69 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History